Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluations.
about
Pharmaceutical policies: effects of cap and co-payment on rational use of medicinesPharmaceutical policies: effects of financial incentives for prescribersPharmaceutical policies: effects of reference pricing, other pricing, and purchasing policiesAdherence to beta-blocker therapy under drug cost-sharing in patients with and without acute myocardial infarctionEmergency hospital admissions after income-based deductibles and prescription copayments in older users of inhaled medications.Evaluating the impact of a novel restricted reimbursement policy for quinolone antibiotics: a time series analysisDrug reimbursement policies in Canada--need for improved access to critical therapies.The effect of Medicare Part D coverage on drug use and cost sharing among seniors without prior drug benefitsThe Validity of the Comparative Interrupted Time Series Design for Evaluating the Effect of School-Level Interventions.Fair tests of health-care policies and treatments: a request for help from readers.Impact of a criteria-based reimbursement policy on the use of respiratory drugs delivered by nebulizer and health care services utilization in Nova Scotia, Canada.Drug expenditure of high-cost patients and their characteristics in Finland.Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias.
P2860
Q24188009-A1C4D86A-AB4A-45D3-9162-7B92C8728DC4Q24243902-FD18ADB6-580A-488F-9DDB-1380D83180BCQ24246148-598E17BC-7E72-4ABC-8B1C-505E29E1699EQ34001855-25D2C136-D8B5-4DDC-B704-9E24399FB586Q34001895-DB42EE67-1B52-4F80-8BFB-20759094AC05Q34398177-76ABA3F7-C35E-4A0E-85FE-F8EDCEC0C0AAQ37162899-C5A5B2FB-068C-42AC-9A1F-3C2D2BB3E324Q37196554-C99C6F08-223D-4157-96FB-83F312A77C50Q39462137-7178F84B-996B-4D36-9612-839423A98FF0Q43122822-C6579937-AF6D-4AD6-BF8E-C22146604AB0Q46148283-51D52EF5-991B-4B73-B97B-C60AB4069396Q51184451-9BD856ED-613A-4C5D-82A7-AB7371725090Q53086583-1DDAD1CC-3D6F-40C8-81D8-A904B8ED99A2
P2860
Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 February 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical and economic conseque ...... and observational evaluations.
@en
Clinical and economic conseque ...... and observational evaluations.
@nl
type
label
Clinical and economic conseque ...... and observational evaluations.
@en
Clinical and economic conseque ...... and observational evaluations.
@nl
prefLabel
Clinical and economic conseque ...... and observational evaluations.
@en
Clinical and economic conseque ...... and observational evaluations.
@nl
P2093
P2860
P1433
P1476
Clinical and economic conseque ...... and observational evaluations
@en
P2093
Jerry Avorn
Malcolm Maclure
Robert J Glynn
Sebastian Schneeweiss
P2860
P356
10.1136/BMJ.38020.698194.F6
P407
P577
2004-02-24T00:00:00Z